Showing results (41-50 of 128) with videos related to
Sort By:
Pageof 13
Blood|August 19, 2004
Impaired CD40L signaling is a cause of defective IL-12 and TNF-alpha production in Sézary syndrome: circumvention by hexameric soluble CD40LLars E French, Bertrand Huard, Maria Wysocka, et al.Clinical Lymphoma & Myeloma|January 19, 2007
High clinical response rate with multimodality immunomodulatory therapy for Sézary syndromeStephen K Richardson, Julie H Lin, Carmela C Vittorio, et al.The Journal of Investigative Dermatology|July 5, 2022
The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 DepletionLei Zhao, Tony Hsiao, Connor Stonesifer, et al.Journal of the American Academy of Dermatology|March 21, 2006
Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patientEun Ji Kwon, Kenneth A Katz, Karla S Draft, et al.Clinical Immunology (Orlando, Fla.)|March 13, 2015
Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalitiesFiliberto Cedeno-Laurent, Elisha M Singer, Maria Wysocka, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 25, 2002
New biologic agents for the treatment of cutaneous T-cell lymphomaCarmela C Vittorio, Jacqueline M Junkins-Hopkins, Karen S McGinnis, et al.Advances in Dermatology|January 17, 2003
Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphomaAlain H Rook, Jacqueline M Junkins-Hopkins, Karen S McGinnis, et al.Blood|October 18, 2002
Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokinesMaria Wysocka, Mohamed H Zaki, Lars E French, et al.Journal of Cutaneous Pathology|January 14, 2017
Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoidesFiliberto Cedeno-Laurent, Maria Wysocka, Amrom E Obstfeld, et al.Blood Advances|September 2, 2022
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clonesLauren C Shaw, Mathilde Poussin, Alba Rodriguez-Garcia, et al.Pageof 13